CYTOCHALASIN B

CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with CYTOCHALASIN B?

CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B

MeSH term MeSH ID Detail
Kidney Diseases D007674 29 associated lipids
Leukemia D007938 74 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Leukemia, Lymphoid D007945 18 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lymphoma D008223 18 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Melanoma D008545 69 associated lipids
Neutropenia D009503 15 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Pharyngeal Neoplasms D010610 4 associated lipids
Pituitary Neoplasms D010911 4 associated lipids
Starvation D013217 47 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Per page 10 20 50 100 | Total 79

PubChem Associated disorders and diseases

What pathways are associated with CYTOCHALASIN B

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with CYTOCHALASIN B?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with CYTOCHALASIN B?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with CYTOCHALASIN B?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with CYTOCHALASIN B?

Xenograft Model

Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with CYTOCHALASIN B

Download all related citations
Per page 10 20 50 100 | Total 4982
Authors Title Published Journal PubMed Link
Johnson E et al. Evidence that agarose must be internalized to stimulate mouse macrophages in vitro. 1982 Scand. J. Immunol. pmid:6186014
MacDonald HR et al. Antibody-dependent cell-mediated cytotoxicity: heterogeneity of effector cells in human peripheral blood. 1975 Scand. J. Immunol. pmid:52180
Saltz L et al. Augmentation by cytochalasin B of antigen receptor-mediated activation of normal and malignant human B lymphocytes. 1990 Scand. J. Immunol. pmid:2105526
Bonnard GD et al. Cell-mediated lympholysis after sensitization in unidirectional mixed lymphocyte culture in man. 1974 Scand. J. Immunol. pmid:4275198
Dickmeiss E Comparative study of antibody-dependent and direct lymphocyte-mediated cytotoxicity in vitro after alloimmunization in the human. II. Chemical inhibitors. 1974 Scand. J. Immunol. pmid:4218363
Halbwachs L and Lachmann PJ Factor B of the alternative complement pathway on human lymphocytes. 1976 Scand. J. Immunol. pmid:824718
Follin P et al. Mechanisms in neutrophil priming: characterization of the oxidative response induced by formylmethionyl-leucyl-phenylalanine in human exudated cells. 1991 Scand. J. Immunol. pmid:1652787
Obel N Staphylococcus albus-induced protein kinase C translocation in human neutrophils: the effect of opsonization, cytochalasin B, pertussis toxin, intra- and extracellular calcium, and R59022. 1992 Scand. J. Immunol. pmid:1325668
Danielsen H et al. The interaction between cell-surface antigens and antibodies bound to monodisperse polymer particles in normal and malignant cells. 1986 Scand. J. Immunol. pmid:3749814
Fleer A et al. Destruction of sensitized erythrocytes by human monocytes in vitro: effects of cytochalasin B, hydrocortisone and colchicine. 1978 Scand. J. Immunol. pmid:734355
Barber TA and Alter BJ Ultrastructure of effector--target cell interaction in secondary cell-mediated lympholysis. 1978 Scand. J. Immunol. pmid:635473
Gullberg R and Norberg R The inhibitory effect of IgM RF on the release of lysosomal substances. 1976 Scand. J. Rheumatol. pmid:1006208
Murray SA and Tung HN Effects of cytochalasin B and colchicine on the morphology of SW-13 human adrenal cortical tumor cells in culture. 1988 Scanning Microsc. pmid:3399847
Braet F et al. Comparative scanning, transmission and atomic force microscopy of the microtubular cytoskeleton in fenestrated liver endothelial cells. 1996 Scanning Microsc. Suppl. pmid:9601542
Huang CY et al. Glaucumolides A and B, Biscembranoids with New Structural Type from a Cultured Soft Coral Sarcophyton glaucum. 2015 Sci Rep pmid:26531161
Zheng Y et al. The relationship between vacuolation and initiation of PCD in rice (Oryza sativa) aleurone cells. 2017 Sci Rep pmid:28117452
Hosaka S et al. Effects of cytochalasin B and colchicine on the motility and growth of Yoshida sarcoma cells in vitro. 1980 Sci Rep Res Inst Tohoku Univ Med pmid:7313677
Perreault F et al. Genotoxic effects of copper oxide nanoparticles in Neuro 2A cell cultures. 2012 Sci. Total Environ. pmid:23137976
Taylor A et al. Vasopressin: possible role of microtubules and microfilaments in its action. 1973 Science pmid:4352609
Krystosek A and Seeds NW Plasminogen activator release at the neuronal growth cone. 1981 Science pmid:7197054